ロード中...
Science review: Recombinant human erythropoietin in critical illness: a role beyond anemia?
Erythropoiesis usually fails during severe illness because of a blunting of the kidney–erythropoietin (EPO)–bone marrow axis. In this setting, clinical studies have shown that recombinant human erythropoietin (rhEPO), administered in pharmacological amounts, significantly reduces the need for blood...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1065012/ https://ncbi.nlm.nih.gov/pubmed/15469595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc2897 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|